slides · global inventory
27 Cost Of Inaction
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 31,900
Current window 17,101-17,130
Pages 1,064
Rows per page 30
Loop
17,101-17,130 of 31,900
11
Includes HEDIS quality score and NCQA certification metrics at the bottom.Cano Health | Investor Presentation Deck | 21 slides · Cano Health
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
12
The slide uses two bar charts to illustrate the 'bending of the cost curve' through a reduction in medical costs over time.Cano Health | Investor Presentation Deck | 21 slides · Cano Health
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
08
The slide uses a table to categorize drugs by therapeutic area (Oncology, Rare Disease, CNS, Infectious Disease, Gastroenterology, Cardiovascular, Other).Certara | Investor Presentation Deck | 30 slides · Certara
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
03
The slide uses a central hub-and-spoke style layout to contrast 'Scale' and 'Low Cost' pillars.Cipher Mining | Investor Presentation Deck | 19 slides · Cipher Mining
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
03
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide is divided into Senior Executive Team (CEO, COO, CSO, CMC, VPs) and Board of Directors.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · TeamLoop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style layout to track clinical phases and regulatory milestones.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
06
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
07
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide presents key clinical trial results for a drug candidate, focusing on response rates.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
09
Uses the Simon 2-Stage adaptive design framework.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
10
The slide highlights a specific row (2 prior systemic therapies) with a red box.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
11
The chart uses a standard oncology waterfall plot format to visualize tumor shrinkage.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
12
Standard clinical trial swimmer plot showing treatment duration, response (PR/SD), progression (PD), death, and ongoing status.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProductLoop · Cost Of Inaction1 hit
13
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
15
Includes comparative data against FOLFOX and TOPAZ-1.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
17
Includes a molecular visualization of the antibody-receptor interaction.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
18
The slide uses medical imaging (CT scans) to demonstrate treatment efficacy.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
19
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
20
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
21
The slide uses a process flow to show the transition from testing a hypothesis to the identification of the lead candidate CTX-8371, supported by two experimental charts.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
22
Compass Therapeutics | Investor Presentation Deck | 23 slidesCompass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
23
The slide uses a visual legend (checkmarks for completed, stars for in-progress) to track status of specific drug development milestones.Compass Therapeutics | Investor Presentation Deck | 23 slides · Compass Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
Clinical context slide likely used to establish the unmet need for second-line treatment options.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
17
The slide highlights the limited progression-free survival (PFS) with a red box around the PFS column.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
18
The slide uses a process flow to illustrate clinical guidelines.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
19
BTC likely stands for Biliary Tract Cancer.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
20
This is a standard academic citation slide.Compass Therapeutics | Investor Presentation Deck | 36 slides · Compass Therapeutics
Pitch deck Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit